Roberto Cuca bought $145k of TELA
COO and CFO at TELA Bio, Inc.. 64,444 shares at an average of $2.25, traded Oct 24, 2024, filed Oct 24, 2024.
Score components
- +22RoleCFO
- +11Trade size$145k at market
- +10Relative to holdingsHoldings up 71%
- 0Price contextNo price history yet
- +15Cluster4 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +16.7%, 3m +2.7%, 6m -62.3%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001062993-24-017930, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 24, 2024 | POpen-market purchase Common Stock | +64,444 | $2.25 | $145k | 155,388 | Oct 24, 2024 |
Related signals
Other insiders at TELA Bio, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 39Weak | TELAbuy TELA Bio, Inc. | Joseph H Capper director | $89k 75,000 shares | +72% | |
| 34Weak | TELAbuy TELA Bio, Inc. | Joseph H Capper director | $78k 75,000 shares | +251% | |
| 50Moderate | TELAbuy TELA Bio, Inc. | Ew Healthcare Partners Fund 2, L.p. owner, other | $4.0M 3,604,000 shares | +88% | |
| 33Weak | TELA Bio, Inc. | Gregory A. Firestone Chief Commercial Officer | $15k 6,666 shares | +13% | |
| 58Moderate | TELA Bio, Inc. | Antony Koblish Chief Executive Officer | $200k 88,888 shares | +24% | |
| 43Moderate | TELA Bio, Inc. | Paul Talmo Chief Technology Officer | $50k 22,222 shares | +32% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.